TGFBR2 and cancer: Specifically, we found that the TGF-ß pathway is disrupted via a combination of largely mutually exclusive events in addition to the frequent disruption of SMAD4. This includes loss of TGFBR2/TGFBR1, as well as mutations in ACVR1B, which is a newly identified cancer-associated gene in the pathway18.